InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Krakaris Emmanuel, Chairman & CEO. Insider active across 2 companies, notably Augmedix, Inc.. Cumulatively, 5 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €173k. History available since 28 October 2021. The latest transaction was disclosed on 2 October 2024 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Krakaris Emmanuel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
64,748 shares@ US$2.35100.0% of flowCommon StockSEC:0001213900-24-085342:0
9,375 sharesCommon StockSEC:0001213900-24-070862:0
9,375 sharesCommon StockSEC:0001213900-24-044877:0
15,551 shares@ US$3.2025.6% of flowCommon StockSEC:0001213900-21-062044:0
Canonical exit: 22 Feb 2022 (T+90)
37,500 shares@ US$4.0074.4% of flowCommon StockSEC:0001213900-21-055925:0
Canonical exit: 26 Jan 2022 (T+90)
5 of 5 declarations
About Krakaris Emmanuel
Emmanuel Krakaris is the Chairman & CEO and Secretary of Augmedix, Inc. He is responsible for the strategic direction of the company, ensuring its development and compliance. Emmanuel plays a key role in the innovation and enhancement of the services offered by Augmedix.
